Augmenter of liver regeneration inhibits apoptosis of activated human peripheral blood lymphocytes in vitro

Immunopharmacology and Immunotoxicology

Volumn 35, Issue 2, 2013, Pages 257-263

  Wang, Na ^a   Sun, Hang ^a   Shen, Yan ^a   Li, Xiao Fang ^a   Pan, Tao ^a   Liu, Guang Liang ^a   Liu, Qi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Augmenter of liver regeneration; Cytokine lymphocytes; Signal pathways

Indexed keywords

CASPASE 3; CASPASE 8; CONCANAVALIN A; INTERLEUKIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; RECOMBINANT HUMAN AUGMENTER OF LIVER REGENERATION; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; CYTOCHROME C; CYTOCHROME REDUCTASE; GFER PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; AUGMENTER OF LIVER REGENERATION; CELL PROLIFERATION; CELL VIABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LIVER REGENERATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MITOCHONDRION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION; UBIQUITINATION; WESTERN BLOTTING; DRUG EFFECTS; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 8; CONCANAVALIN A; CYTOCHROME REDUCTASES; CYTOCHROMES C; CYTOSOL; HUMANS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LIVER REGENERATION; LYMPHOCYTES; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS;

EID: 84875017007     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2013.764502     Document Type: Article

References (53)

1. Strasser A, Pellegrini M. T-lymphocyte death during shutdown of an immune response. Trends Immunol 2004;25:610-15.
2. Chakrabarti LA, Simon V. Immune mechanisms of HIV control. Curr Opin Immunol 2010; 22:488-96.
3. Gougeon ML, Piacentini M. New insights on the role of apoptosis and autophagy in HIV pathogenesis. Apoptosis 2009;14:501-8.
4. Bijl M, Horst G, Limburg PC, Kallenberg CG. Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): Relation to lymphocyte activation and disease activity. Lupus 2001;10:866-72.
5. Kovacs B, Liossis SN, Dennis GJ, Tsokos GC. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus. Autoimmunity 1997;25:213-21.
6. Xue C, Lan LW, Bei C, et al. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol 2006;239:121-8.
7. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
8. Kim WU, Yoo SA, Min SY, et al. Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes. Clin Exp Immunol 2006;144:503-11.
9. Hagiya M, Francavilla A, Polimeno L, et al. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: Expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci USA 1994;91:8142-6.
10. Francavilla A, Barone M, Van Thiel DH, et al. Further steps of hepatic stimulatory substance purification. Dig Dis Sci 1991;36:674-80.
11. Francavilla A, Hagiya M, Porter KA, et al. Augmenter of liver regeneration: Its place in the universe of hepatic growth factors. Hepatology 1994;20:747-57.
12. Li Y, Farooq M, Sheng D, et al. Augmenter of liver regeneration (alr) promotes liver outgrowth during zebrafish hepatogenesis. PLoS One 2012;7:e30835.
13. Polimeno L, Pesetti B, Annoscia E, et al. Alrp, a survival factor that controls the apoptotic process of regenerating liver after partial hepatectomy in rats. Free Radic Res 2011;45:534-49.
14. Tang L, Sun H, Zhang L, et al. Effects of the augmenter of liver regeneration on the biological behavior of hepatocellular carcinoma. Saudi Med J 2009;30:1001-9.
15. Gao CF, Zhou FG, Wang H, et al. Genetic recombinant expression and characterization of human augmenter of liver regeneration. Dig Dis Sci 2009; 54:530-7.
16. Wang CP, Zhou L, Su SH, et al. Augmenter of liver regeneration promotes hepatocyte proliferation induced by Kupffer cells. World J Gastroenterol 2006;12:4859-65.
17. Gandhi CR. Augmenter of liver regeneration. Fibrogenesis Tissue Repair 2012;5:10.
18. Gandhi CR, Kuddus R, Subbotin VM, et al. A fresh look at augmenter of liver regeneration in rats. Hepatology 1999;29:1435-45.
19. Gandhi CR, Murase N, Starzl TE. Cholera toxin-sensitive GTPbinding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat Kupffer cells. J Cell Physiol 2010;222:365-73.
20. Wang G, Yang X, Zhang Y, et al. Identification and characterization of receptor for mammalian hepatopoietin that is homologous to yeast ERV1. J Biol Chem 1999;274:11469-72.
21. Dayoub R, Thasler WE, Bosserhoff AK, et al. Regulation of polyamine synthesis in human hepatocytes by hepatotrophic factor augmenter of liver regeneration. Biochem Biophys Res Commun 2006;345:181-7.
22. Francavilla A, Vujanovic NL, Polimeno L, et al. The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology 1997;25:411-15.
23. Tanigawa K, Sakaida I, Masuhara M, et al. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J Gastroenterol 2000;35:112-19.
24. Polimeno L, Margiotta M, Marangi L, et al. Molecular mechanisms of augmenter of liver regeneration as immunoregulator: Its effect on interferon-gamma expression in rat liver. Dig Liver Dis 2000;32:217-25.
25. Farrell SR, Thorpe C. Augmenter of liver regeneration: A flavindependent sulfhydryl oxidase with cytochrome c reductase activity. Biochemistry 2005;44:1532-41.
26. Wu CK, Dailey TA, Dailey HA, et al. The crystal structure of augmenter of liver regeneration: A mammalian FAD-dependent sulfhydryl oxidase. Protein Sci 2003;12:1109-118.
27. Lisowsky T, Lee JE, Polimeno L, et al. Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. Dig Liver Dis 2001;33:173-80.
28. Daithankar VN, Farrell SR, Thorpe C. Augmenter of liver regeneration: Substrate specificity of a flavin-dependent oxidoreductase from the mitochondrial intermembrane space. Biochemistry 2009;48:4828-37.
29. Thirunavukkarasu C, Wang LF, Harvey SA, et al. Augmenter of liver regeneration: An important intracellular survival factor for hepatocytes. J Hepatol 2008;48:578-88.
30. Polimeno L, Pesetti B, Lisowsky T, et al. Protective effect of augmenter of liver regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Free Radic Res 2009;43:865-75.
31. Cao Y, Fu YL, Yu M, et al. Human augmenter of liver regeneration is important for hepatoma cell viability and resistance to radiation-induced oxidative stress. Free Radic Biol Med 2009;47:1057-66.
32. Todd LR, Damin MN, Gomathinayagam R, et al. Growth factor erv1-like modulates Drp1 to preserve mitochondrial dynamics and function in mouse embryonic stem cells. Mol Biol Cell 2010;21:1225-36.
33. Liao XH, Zhang L, Liu Q, et al. Augmenter of liver regeneration protects kidneys from ischaemia/reperfusion injury in rats. Nephrol Dial Transplant 2010;25:2921-9.
34. Polimeno L, Pesetti B, De Santis F, et al. Decreased expression of the augmenter of liver regeneration results in increased apoptosis and oxidative damage in human-derived glioma cells. Cell Death Dis 2012;3:e289. doi: 10.1038/cddis.2012.25.
35. Liao XH, Chen GT, Li Y, et al. Augmenter of liver regeneration attenuates tubular cell apoptosis in acute kidney injury in rats: The possible mechanisms. Ren Fail 2012;34:590-9.
36. Ilowski M, Kleespies A, de Toni EN, et al. Augmenter of liver regeneration (ALR) protects human hepatocytes against apoptosis. Biochem Biophys Res Commun 2011;404:148-52.
37. Liu Q, Yu HF, Sun H, Ma HF. Expression of human augmenter of liver regeneration in Pichia pastoris yeast and its bioactivity in vitro. World J Gastroenterol 2004;10:3188-90.
38. Xie H, Sun H, Guo H, Liu Q. The effect of rhALR on the proliferation and IL-2 production of spleen mononuclear cells of rat in vitro. J Chin Immunol 2007;23:467-70.
39. Hutchenson J, Scatizzi JC, Siddiqui AM, et al. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 2008;28:206-17.
40. Hughes PD, Belz GT, Fortner KA, et al. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 2008;28:197-205.
41. Brenner D, Krammer PH, Arnold R. Concepts of activated T cell death. Crit Rev Oncol Hematol 2008;66:52-64.
42. Krammer PH, Arnold R, Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol 2007;7:532-42.
43. Hildeman DA, Zhu Y, Mitchell TC, et al. Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol 2002;14:354-9.
44. Hildeman DA, Zhu Y, Mitchell TC, et al. Activated T cell death in vivo mediated by proapoptotic bcl-2-family member bim. Immunity 2002;16:759-67.
45. Marsden VS, Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 2003;21:71-105.
46. Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000;69:217-45.
47. Lee J, Hofhaus G, Lisowsky T. Erv1p from Saccharomyces cerevisiae is a FAD-linked sulfhydryl oxidase. FEBS Lett 2000;477:62-6.
48. Lange H, Lisowsky T, Gerber J, et al. An essential function of the mitochondrial sulfhydryl oxidase Erv1p/ALR in the maturation of cytosolic Fe/S proteins. EMBO Rep 2001;2:715-20.
49. Kim JS, He L, Qian T, Lemasters JJ. Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes. Curr Mol Med 2003;3:527-35.
50. Lenardo M, Chan KM, Hornung F, et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999;17:221-53.
51. Siegel RM, Chan FK, Chun HJ, Lenardo M. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 2000;1:469-74.
52. Wajant H. The Fas signaling pathway: More than a paradigm. Science 2002;296:1635-6.
53. Saint Fleur S, Hoshino A, Kondo K, et al. Regulation of Fasmediated immune homeostasis by an activation-induced protein, Cyclon. Blood 2009;114:1355-65.